In vitro anti-tumor immune response induced by dendritic cells transfected with hTERT recombinant adenovirus
- 29 December 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 351 (4) , 927-934
- https://doi.org/10.1016/j.bbrc.2006.10.165
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHDBlood, 2006
- The role of telomeres and telomerase in the pathology of human cancer and agingPathology, 2006
- Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cellsWorld Journal of Urology, 2005
- Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate CancerThe Journal of Immunology, 2005
- Vaccination of Cancer Patients Against Telomerase Induces Functional Antitumor CD8+ T LymphocytesClinical Cancer Research, 2004
- In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenovirusesVaccine, 2003
- Adoptive T cell therapy using antigen-specific CD8+T cell clones for the treatment of patients with metastatic melanoma:In vivopersistence, migration, and antitumor effect of transferred T cellsProceedings of the National Academy of Sciences, 2002
- Alterations of telomerase activity and terminal restriction fragment in gastric cancer and its premalignant lesionsJournal of Gastroenterology and Hepatology, 2001
- Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigensVox Sanguinis, 2001
- Dendritic cells and the control of immunityNature, 1998